London, United Kingdom
Cryogenx, with its slogan "Medical technology for a hotter planet," is a promising player in the Health Care, Manufacturing, and Medical Devices industries. Based in the United Kingdom, this company addresses the escalating global health concern of heat-related ailments through innovative solutions.
Their flagship product, the Cryogenx CGX1, is a portable, on-demand cooling device aimed at revolutionizing heatstroke treatment by emulating ice bath immersion with minimal resources. As the rising global temperatures pose a threat—potentially costing economies $2.4 trillion by 2030—Cryogenx positions itself as a crucial solution provider in mitigating heat stress effects.
Receiving a recent €1.90 million seed investment on 15 July 2025, backed by Future Planet Capital and the UK Innovation & Science Seed Fund (UKI2S), Cryogenx exhibits strong investor confidence and potential for significant impact in its target markets.
